Latest News about JNJ
Recent news which mentions JNJ
From Benzinga
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Omicron variant remains a ‘very high’ risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it’s more lethal
December 15, 2021
From MarketWatch
From MarketWatch
10 Stocks to Buy if You Have $5,000 in Starter Money
December 14, 2021
From InvestorPlace
Investing in an Alternative Asset Like an NFT? This Company Says It May Have Better Options
December 14, 2021
From Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
From Benzinga
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
From Benzinga
UK Reports First Omicron Death, PM Johnson Encourages Boosters
December 13, 2021
From Benzinga
Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting
December 13, 2021
Tickers
JNJ
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
From Benzinga
How Quickly Could Vaccines Targeting the Omicron Variant Be Available?
December 11, 2021
From Motley Fool
What Does the Omicron Variant Mean for Vaccine Stocks?
December 11, 2021
From Motley Fool
With Johnson & Johnson, Toshiba, and GE Splitting, Could Other Big Companies Follow Suit?
December 11, 2021
From Motley Fool
3 Bright Investment Ideas for a Millionaire Retirement
December 11, 2021
From Motley Fool
How Will the Omicron Variant Impact Moderna Stock?
December 10, 2021
From Motley Fool
3 Healthcare Stocks for Long-Term Dividend Growth
December 10, 2021
From InvestorPlace
Here's What Investors Need to Know About Johnson & Johnson's Split
December 10, 2021
Tickers
JNJ
From Motley Fool
Is Johnson & Johnson's Upcoming Split Good or Bad News for Investors?
December 10, 2021
Tickers
JNJ
From Motley Fool
4 Stocks That Could Be Worth $1 Trillion by 2035
December 10, 2021
From Motley Fool
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants
December 09, 2021
From Benzinga
‘I think it’s coming’ Why employers could start requiring boosters as omicron spreads
December 09, 2021
From MarketWatch
3 Investors Pick Their Favorite Dividend Stocks
December 08, 2021
From Motley Fool
Big Companies Are Splitting: 1 Investor Weighs In
December 08, 2021
From Motley Fool
From InvestorPlace
Vaccine Stocks: The Beginning of the End?
December 06, 2021
From Motley Fool
‘Should I visit family?’ 3 ways to stay safer against COVID-19 omicron variant during the holiday season
December 06, 2021
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.